Analysis of molecular heterogeneity of PRL is important in patients with hyperprolactinemia
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue
Abstract
Assessment of prolactin level in a medical laboratory is most frequently related to verifying the cause of the problems with fertility. However, hyperprolactinaemia diagnosis by laboratory test often does not reflect the clinical condition of a patient. Patients with hyperprolactinemia, but without characteristic symptoms related to this disorder, undergo further biochemical and/or image diagnosis, which could be harmful to the human organism. In some cases, pharmacological treatment and even surgical intervention are applied, although the cause of elevated prolactin levels has not been identified. Prolactin is present in blood in different forms and/or complexes. Most frequently, three basic isoforms of this hormone are distinguished: monomeric prolactin, big-prolactin, and big-big-prolactin, called a macroprolactin. The listed forms of prolactin have different biological activity, but in laboratory tests, all of them show immunoreactiveness. For that reason, prolactin is a large problem for laboratory diagnosticians and clinicians. The analysis of the presence of macroprolactin in blood samples with elevated prolactin level is not a routine matter, even though it has a key meaning in the further diagnostic process of hyperprolactinemia. A gold standard identifying all forms of prolactin is gel filtration chromatography, which gives qualitative and also quantitative results. Unfortunately, the equipment used for this method is not commonly available in medical laboratory. Results of many studies showed that the precipitation of macroprolactin with polyethylene glycol could be the screening method for evaluating the macroprolactinaemia prevalence. This procedure is simple and relatively low-cost, and though it has some analytical restrictions, its results correlate well with the results of the gel filtration chromatography. Macroprolactinaemia is present in a small percentage of the total population; however, it can occured in 53% patients with hyperprolactinaemia.
Authors and Affiliations
Izabela Kokot, Sylwia Płaczkowska, Lilla Pawlik-Sobecka
Keywords
Related Articles
- EP ID EP248753
- DOI 10.5604/01.3001.0010.7732
- Views 144
- Downloads 0
Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease
Huntington’s disease (HD) is an incurable, devastating neurodegenerative disease with a known genetic background and autosomally dominant inheritance pattern. HTT gene mutation (mHTT) is associated with polymorphic fragm...
Congenital myopathies – skeletal muscle diseases related to disorder of actin filament structure and functions
Congenital myopathies are clinically and genetically heterogeneous disorders characterized by muscle structural abnormalities, muscle weakness and deformities. The clinical spectrum of the disease ranges from severe ca...
Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study
Introduction: Hepatitis C virus (HCV) infection is a worldwide problem and hepatitis, which is its natural unfavourable course, is still a challenge for hepatologist. At present, standards of treatment are changing from...
Blood groups – minuses and pluses. Do the blood group antigens protect us from infectious diseases?
Human blood can be divided into groups, which is a method of blood classification based on the presence or absence of inherited erythrocyte surface antigens that can elicit immune response. According to the International...
Age-Related Changes in the Central Nervous System in Selected Domestic Mammals and Primates
Aging is a process which operates at many levels of physiological, genetic and molecular organizationand leads inevitably to death [18]. Brain macroscopic changes by MRI investigation during aging were observed in humans...